Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

6

Gov't Entities

2

Filing Information
Filing UUID:
5d1bc0f4-7a87-48c0-a9b0-fc3ac8418ff1
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 6:49 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: James "J.D." Derderian
Registrant
STANTON PARK GROUP

government affairs

Annapolis, Maryland
Client
VERTEX PHARMACEUTICALS INCORPORATED

Global biotechnology company

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375

Lobbyists (6)
  • VALERIE HENRY
  • JAMES DERDERIAN
  • JOSEPH RACHINSKY JR
  • MR. BRYAN WILLIAM WELLS
  • AISLING MCDONOUGH
  • KEVIN DAWSON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.